Genomtec SA logo — Molecular diagnosis everywhere, at the right time and for th...

Genomtec SA

Molecular diagnosis everywhere, at the right time and for the right price.

Founded 2016 Poland Poland 26 employees Grant Total: $26.50M Biotechnology, Health Care +2

General Information

Company Name Genomtec SA
Founded Year 2016
Location Poland Poland +1
Employees 26
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Grant
Social

Get notified when Genomtec SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genomtec SA

Genomtec is a MedTech company founded in 2016 with the slogan "Molecular diagnosis everywhere, at the right time and for the right price." The company specializes in advanced technologies for genetic diagnostics. Their flagship project, the Genomtec ID mobile diagnostic system, holds EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, enabling fast and precise molecular analysis for common respiratory tract infections. The technology, protected by 11 patents and over 35 pending applications across global markets, utilizes microfluidic and proprietary patented SNAAT® isothermal technology. With a focus on biotechnology and healthcare, Genomtec is headquartered in Wroclaw, Poland and has a branch in the UK. Their second project, "OncoSNAAT," aims to develop automated mutation detection technology for clinical oncology utilizing lab-on-chip solutions. The company has recently received a PLN21.60M grant investment on 29th December 2023 from the Polish Agency for Enterprise Development. Genomtec's team comprises experienced individuals from various fields, combining confidence in molecular diagnostics with simplicity and cost reduction. With a passion for creation, the company works with young, ambitious scientists and constructors, alongside seasoned experts in commercialization and effective market strategies.

Taxonomy: Molecular Diagnostics, Genetic Analyzer, Mobile Technology, Infection Detection, Antibiotic Resistance, Cancer Cases, Biological Material Testing, R&D, Medtech, Diagnostic Technology, Healthcare Innovation, Genomic Analysis, Medical Device, Biomedical Engineering

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
29 Dec 2023
Funding Round •••••• - 28 Apr 2023
Seed Round •••••• 1
Investor
09 Oct 2020

Genomtec SA Alternatives & Competitors

Genomtec SA vs
Paratus Diagnostics
Paratus Diagnostics United States

Advancing Diagnostic Technology

Series Unknown
3 employees
Biotechnology, Health Care
Genomtec SA vs
Incyte Diagnostics
Incyte Diagnostics United States

The Pacific Northwest's premier laboratory, recognized for diagnostic excellence, professionalism an...

277 employees
Health Care, Life Sciences
Genomtec SA vs
Genomate Health
Genomate Health United States

The right drug. The first time. Every time.™ Pioneering Digital Drug Assignment for Precision Onco...

Seed
29 employees
Biotechnology, Health Care

FAQ About Genomtec SA

Molecular diagnosis everywhere, at the right time and for the right price.
Genomtec SA was founded in 2016.
Genomtec SA is headquartered in Poland.
Genomtec SA operates in the following industries: Biotechnology, Health Care, Life Sciences, Medical Devices.
Genomtec SA has approximately 26 employees.
Genomtec SA has completed 3 funding rounds, raising a total of $26.50M. The latest funding stage is Grant.
Top alternatives and competitors to Genomtec SA include Paratus Diagnostics, Incyte Diagnostics, Genomate Health, Allianz BioInnovation, BioGX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genomtec SA and Paratus Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genomtec SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy